Based on reports from Nuclear Medicine Europe and suppliers, ASNC is expecting disruptions to Mo-99 supply in the coming weeks. The shortage is a result of unexpected required maintenance on the high-flux reactor (HFR) in Petten, Netherlands.
A reactor inspection determined that a previously identified pipe deformation must be corrected immediately, rather than as a planned fix scheduled for the December 2024 maintenance period. NRG, the operator of the HFR reactor, has not announced a start date; however, the fix will likely take a few weeks to complete.
Unfortunately, this necessary fix coincides with the planned maintenance periods of several other reactors, and it appears that schedules cannot be adjusted.
Suppliers are reporting that limited quantities of Mo-99 may be available during the next several weeks but that forecasting is difficult at this time. As the situation may evolve quickly, ASNC is encouraging members to contact their local nuclear pharmacies for up-to-date information on Mo-99 supply.
Stay tuned to ASNC for further updates.
Article Type
News & Announcements
Category
Advocacy, Membership
Related Posts
More HMDP Coming in Late March, Radiopharmaceutical Manufacturer Says
Following supply issues starting in January, ASNC is maintaining close contact with…
CMS Names Physicians Required to Participate in New Heart Failure Payment Model
The Centers for Medicare & Medicaid Services (CMS) has released a searchable…
Immediate Impact! ASNC Statement Driving Cardiac PET Adoption Across the United States
“ASNC’s Clinical Indications for PET statement got the attention of our hospital…


